Previously treated cases tested for RR-/MDR-TB (%) in Nepal

Nepal: Previously treated cases tested for RR-/MDR-TB was 81.0% in 2024. ◆ Volatile

Latest (2024)
81.0%
Change on year
up 3.8%
World rank
111th
of 180 countries
All-time high
96.0%
in 2020
All-time low
0.0%
in 2011
Years of data
18
2007–2024

Previously treated cases tested for RR-/MDR-TB in Nepal, 2007–2024

0204060801002007201520242007: 172008: 102009: 7.12010: 6.22011: 02012: 242013: 252014: 262015: 282016: 902017: 292018: 562019: 852020: 962021: 642022: 782023: 782024: 81

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Nepal is 81.0%, measured in 2024.

The figure is up 3.8% on the previous year and up 211.5% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Nepal peaked at 96.0% in 2020 and was at its lowest, 0.0%, in 2011.

That places Nepal 111th out of 180 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Nepal, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Nepal, 2007 to 2024.
Year Value Change
2007 17.0% —
2008 10.0% -41.2%
2009 7.1% -29.0%
2010 6.2% -12.7%
2011 0.0% -100.0%
2012 24.0% —
2013 25.0% +4.2%
2014 26.0% +4.0%
2015 28.0% +7.7%
2016 90.0% +221.4%
2017 29.0% -67.8%
2018 56.0% +93.1%
2019 85.0% +51.8%
2020 96.0% +12.9%
2021 64.0% -33.3%
2022 78.0% +21.9%
2023 78.0% +0.0%
2024 81.0% +3.8%

Nepal compared with similar countries

  • Nepal's 81.0% is below the median for lower middle income countries, which is 90.0%, 90% of the median. (47 countries reporting)
  • Nepal's 81.0% is below the median for South Asia, which is 93.0%, 87% of the median. (6 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 11.4% 7.1% 17.0% 3
2010s 36.9% 0.0% 90.0% 10
2020s 79.4% 64.0% 96.0% 5

Countries ranked near Nepal

  1. 111 Croatia 81.0% compare
  2. 111 Denmark 81.0% compare
  3. 114 Poland 80.0% compare
  4. 114 Latvia 80.0% compare
  5. 114 Germany 80.0% compare

See the full ranking of 193 places →

More health data for Nepal

All data for Nepal →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Nepal?
Previously treated cases tested for rr-/mdr-tb in Nepal was 81.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Nepal?
The highest recorded value was 96.0% in 2020.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Nepal?
The lowest recorded value was 0.0% in 2011.
How does Nepal rank for previously treated cases tested for rr-/mdr-tb?
Nepal ranks 111th out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Nepal?
Over the last ten years it is up 211.5%. The long-run trend across the full record is volatile.
Where does this Nepal data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Nepal. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/nepal/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/nepal/">Previously treated cases tested for RR-/MDR-TB in Nepal</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed